Our leadership team inspires and challenges every aspect of the organization to develop life-changing solutions for the patients of today and tomorrow. Along with their peers who sit overseas, this dynamic and experienced group of U.S.-based leaders enable us to create innovative medicines that can change the standard of care.
Corporate Management
Global Oncology Business (U.S.-based leaders)
Ken Keller
Chairman of the Board, President and Chief Executive Officer of Daiichi Sankyo, Inc. and Global Head of the Daiichi Sankyo Oncology Business
Research & Development (U.S.-based leaders)
U.S. Oncology Business
Other U.S.-based leaders
James Felix
Head of Global Digital Transformation (DX), Chief Digital Transformation Officer
read more
Daiichi Sankyo, Inc. Board of Directors
| Chairman of the Board, Corporate President & CEO | Ken Keller |
|---|---|
| Director | Dick Van Duyne |
| Director, Global Head of R&D | Ken Takeshita |
| Director, Head of US Oncology Business Div. | Dan Switzer |
| Director (Independent) | Hiroyuki Fujita*1 |
1Hiroyuki Fujita is the Chairman of Canon Healthcare USA, INC. etc.
To view the Board of Directors of our parent company, Daiichi Sankyo Co., LTD., visit: https://www.daiichisankyo.com/about_us/mission-strength/leadership/
Last Updated: June 2025